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SUPPLEMENTARY NOTES
ABSTRACT
This project involved investigation and optimization of the chemistry needed to immobilize biorecognition elements (BRE) on gold nanoparticles (AuNPs) to create selective nanoprobes for integration in micro-and nano-fluidic platforms to perform biomarker quantification in biofluids. The AuNPs serve as BRE carriers for analyte pre-concentration to be interfaced with a sensor platform that increases overall sensor sensitivity. Thiol coupling approaches were used in the optimization chemistry to immobilize aptamers and peptides on the AuNP surface. The parameters optimized in this work included reaction times, ligand ratio (PEG-OH vs PEG-COOH) and peptide-AuNP ratio. The first design involving an integrated sensor showed successful cortisol detection at biological levels. A competitive assay involving target recognition at the AuNP surface and release of an electroactive signaling molecule for analyte quantification was realized for cortisol detection. The immobilization protocol was monitored by agarose gel electrophoresis, considering the changes in migration patterns after BRE immobilization as indicators of successful BRE attachment. Peptide coupling was also characterized by dynamic light scattering (DLS) and Zeta potential measurements. The advantage of this approach relies on avoiding surface derivatization on the electrochemical sensor, which can compromise sensitivity and efficiency of signal transduction. Moreover, analyte diffusion to the sensor surface is not required, since the analyte is bound by the AuNPs, which are free in solution, and thus accelerate the detection process.
SUBJECT TERMS
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SECURITY CLASSIFICATION OF: 17. LIMITATION OF ABSTRACT
Summary:
The expertise of RHXBC researchers in BRE selection, characterization and chemical derivation for sensor development was utilized to creative responsive bio-nanomaterials that recognized biomarkers of interest in Human Performance studies. Protocols with step-by-step instructions for performing peptides and aptamers surface immobilization were provided to collaborators in order to create nanoprobes that were integrated in micro-and nano-fluidic devices. Our first design with the integrated sensor showed successful cortisol detection in biological levels. A competitive assay where target recognition is performed in the surface of AuNPs and an electroactive signaling molecule was released for analyte quantification was realized.
Introduction: Selective human performance biomarkers quantification is a challenging task since the typical levels of some of these analytes are orders of magnitude lower than other non-relevant species, like albumins and globulins. Therefore, powerful methods for analyte pre-concentration and/or selective binding in biofluids are needed to create technologies that can monitor biomarker signatures in real-time. The use of nanomaterials as BRE carriers and signal transducing elements for analyte detection has revolutionized the field of diagnostics by providing simple means to design highly selective and rapid biosensors. Antibodies have been the BRE of choice for a few decades now, with great success in the detection of multiple biomarkers related to different conditions. However, their performance in non-ELISA type of formats has been relatively unsuccessful. Moreover, the most sensitive sensing platforms proposed for next generation sensors work based on the transduction of a binding event that occur on the sensor surface. Therefore, the use of BREs that can provide a conformational change upon analyte binding or that due to their small size (< 10 nm) perturb the surface properties after analyte binding is crucial for these sensors' signal generation mechanism. Based on this, small peptides (with sequences made of less than 20 amino acids) and DNA aptamers (via on-off structural switching properties) are appealing BREs for new sensors development. In order to allow their use in different sensor formats the chemistry necessary for successful surface immobilization with preserved activity needs to be optimized.
Experiment:
The work performed focused on optimizing the chemistry necessary to immobilize aptamers and peptides on the surface of AuNPs. The AuNPs are meant to serve as BRE carriers for analyte pre-concentration to be interfaced with a sensor platform increasing overall sensor sensitivity.
Aptamer immobilization was performed utilizing thiol coupling to the metal surface. To allow the DNA to chemisorb on the AuNPs surface, the DNA was purchased with a 5' end thiol group. Different parameters were optimized for aptamer immobilization, including DNA-AuNP incubation time, salt aging step, and DNA density control through DNA removal with mercaptohexanol (MCH). The optimized protocol is given as an appendix at the end of the document.
Peptide immobilization was performed by immobilizing a PEG ligand containing a carboxylic acid group (-COOH) in one end and a thiol group at the other end. Similarly to the case with the aptamer BREs, the thiol group was used to attach the ligand on the AuNPs surface and the -COOH was used to couple the peptides through their N-terminus. The parameters optimized in this work included reaction times, ligand ratio (PEG-OH vs PEG-COOH) and peptide-AuNP ratio. The optimized protocol is given as an appendix at the end of the document.
In both cases, the immobilization protocol was monitored by agarose gel electrophoresis, considering the changes in migration patterns after BRE immobilization as indicators of successful BRE attachment. Peptide coupling was also characterized by dynamic light scattering (DLS) and Zeta potential measurements.
Results and Discussion:
Aptamer immobilization on AuNPs is accomplished by attaching the aptamers through a thiol group in one the ends of the DNA sequence, see Figure 1 for a schematic representation of the process. After the first sequences of DNA have been adsorbed, the high density of negative charges prevents more DNA strands to further reach the surface, therefore, NaCl is added to help reduce the electrostatic repulsion and obtain more densely covered AuNPs. Finally, to reduce surface-aptamer interactions, MCH is used as a filler, to fill the gaps in between the different DNA strands and direct the aptamer sequence to the periphery of the AuNPs, increasing the changes for target binding. Also, the MCH layer would prevent adsorption of non-relevant analytes reducing non-specific binding. The gel in Figure 1 shows the difference in electrophoretic mobilities between AuNPs covered with a non-charge-PEG coating layer and two different AuNPs sets, each coated with a different aptamer. The dramatic difference in mobility is due to the high density of negative charges provided by the DNA strands immobilized on the AuNPs.
A number of small peptides that bind targets related to human performance have been previously selected by AF researchers to expand the capabilities of biomarkers that can be monitored to characterize human performance under different conditions. To immobilize these peptides on metal nanoparticles we decided to use a covalent linkage; contrary to the electrostatically-driven coupling typically performed by some groups. The rationale for this choice is given by the fragility of non-covalent binding of the BRE to the nanoparticle, a covalent bond will allow the use of the BRE-NP conjugates in a range of different conditions, including pH, temperature and salt concentrations, which is critical for the conjugates to be used in biofluids. As shown in Figure 2A , the first step of the ligand immobilization deals with the attachment of the HS-PEG-X molecule. In this step we used a combination of HS-PEG-OH and HS-PEG-COOH in order to control the -COOH density, which later in the process will control the density of peptide immobilized. DLS and Zeta potential measurements confirmed that the ligand mixture was deposited on the AuNPs and that the density of Peptide attachment was performed using NHS/EDCcatalyzed amine coupling. AuNPs coated with lower densities of -COOH ligands were used, since they provided a wider range over surface charge and density of reactive site. As shown in Figure 3A , the number of peptide units that could be attached to the AuNPs surface is related to the number of -COOH units previously immobilized on the AuNPs. Figure 3B shows the effect of ligand loading on the electrophoretic mobility of the PEG-OH/PEG-COOH coated AuNPs, with significant difference in mobilities between the 10 and 25% -COOH loadings. Therefore these two loadings were further utilized to performance peptide attachment. Figure 3C shows the change in mobility before and after the peptide coupling reaction, showing that in both cases, 10 and 25 % -COOH loading, the AuNPs' mobility was affected by the reaction with the peptide. Importantly, the gel characterization experiments were performed after extending washing to remove peptides that were not chemically attached. Interestingly, peptide immobilization resulted in higher electrophoretic mobilities in the 10% -COOH AuNPs, but resulted in lower mobilities in the 25% -COHH AuNPs. This could be a combination of the effects of the mass and charge added to the AuNPs surface due to the peptide coupling. At lower -COOH densities the charge of the peptide dominated the effect observed, increasing the AuNPs' electrophoretic mobility, while at higher -COOH loadings (probably close to surface saturation) the dominating effect is the added mass of peptide, reducing their mobility. In both cases, peptide immobilization was confirmed by the change in the AuNPs' electrophoretic mobility after the coupling reaction.
Integration of aptamer-AuNPs conjugates in sensor platform.
The aptamer-AuNPs conjugates were integrated in a sensing platform based on a competitive assay that released an electroactive molecule upon cortisol detection. The advantage of this approach relies on avoiding surface derivatization on the electrochemical sensor, which can compromise sensitivity and efficiency of signal transduction. Moreover, analyte diffusion to the sensor surface is not required, since the analyte is bound by the AuNPs, which are free in solution, accelerating the detection process.
List of Publications and Significant Collaborations that resulted from your AOARD supported project: Peptides were selected through collaboration between AFRL and Wright State University Professor Madhavi Kadakia. The aptamer immobilization protocols developed here were provided to Prof. Nathan Swami to perform the immobilization of a cortisol-binding aptamer on AuNPs. The aptamer was selected by Dr. Jennifer Martin who was a former NRC post-doctoral fellow for Dr. Nancy Kelley-Loughnane at AFRL. The aptamer-AuNPs were utilized to design an assay that detects cortisol using the nano-and micro-fluidics sensor platforms developed in Prof Chia-Fu Chou's (Academia Sinica) and Prof Nathan Swami's (University of Virginia) laboratories.
